Fritextsökning
Innehållstyper
-
Galderma bygger nytt
Planerar ny tillverkningsanläggning i Uppsala och visar upp lovande resultat från studie med ready to use-lösning av botulinumtoxin.
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Ziccum byter till First North och hoppas på covidsamarbete
När covidvaccin ska börja ges i stor skala kommer miljardtals sprutor behöva tas omhand. Svenska Ziccum anser att deras teknik kan användas för att minska det problemet
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Extensive agreements signed at Scilifelab
Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.
-
Efter studien: ”Vi har bäst kombination av effekt och säkerhet”
– Nu förbereder vi oss för fas III, säger vd Peter Zerhouni efter att Index pharmaceuticals når målen i fas IIb-studien med sin läkemedelskandidat mot ulcerös kolit.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Visar lovande ny mekanism mot alzheimer
”Vi är nära ett genombrott i kampen mot Alzheimers sjukdom.” Det var budskapet från Pontus Forsell, forskningschef på AlzeCure, vid mötet 17th International Con...
-
Index tar in dansk toppchef i styrelsen
Lundbecks Stig Løkke Pedersen blir ledamot i Stockholmsbolaget.
-
Calliditas beviljas prioriterad granskning
Calliditas läkemedel Nefecon mot Bergers sjukdom kan bli godkänt av FDA i september.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young...
-
Små containrar levererar vaccin
Det handlar inte bara om biotillgänglighet utan också om administrering – spruta eller piller.
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.